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Conjunctival pneumococcal serotypes among members of a community have not been investigated 
well. We determined the prevalence and association of Streptococcus pneumoniae in the nasopharynx 
and conjunctiva among children in a community before pneumococcal conjugate vaccine introduction. 
In October 2016, conjunctival and nasopharyngeal swabs were collected from children (< 24 months 
old) and nasopharyngeal swabs from mothers in Nha Trang, Vietnam. Quantitative lytA PCR and 
DNA microarray were performed to detect and serotype S. pneumoniae. The association between 
S. pneumoniae in the nasopharynx and conjunctiva was evaluated using multivariable logistic 
regression model. Among 698 children, 62 (8.9%, 95% CI 6.9–11.2%) were positive for S. pneumoniae 
in the conjunctiva. Non‑encapsulated S. pneumoniae were most commonly identified, followed by 
serotypes 6A, 6B, and 14. Nasopharyngeal and conjunctival detection were positively associated 
(aOR 47.30, 95% CI 24.07–92.97). Low birth‑weight, day‑care attendance, and recent eye symptoms 
were independently associated with S. pneumoniae detection in the conjunctiva (aOR 11.14, 95% CI 
3.76–32.98, aOR 2.19, 95% CI 1.45–3.31, and aOR 3.59, 95% CI 2.21–5.84, respectively). Serotypes 
and genotypes in the conjunctiva and nasopharynx matched in 87% of the children. Three mothers’ 
nasopharyngeal pneumococcal samples had matched serotype and genotype with their child’s in the 
conjunctiva and nasopharynx. S. pneumoniae presence in nasopharynx and conjunctiva were strongly 
associated. The high concordance of serotypes suggests nasopharyngeal carriage may be a source of 
transmission to the conjunctiva.
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The conjunctiva is commonly colonized by a diverse range of microorganisms that constitute the normal ocular 
flora. However, these microorganisms are also capable of causing infections of the conjunctiva and  cornea1,2. 
Acute conjunctivitis is one of the most common ocular disorders among children younger than 6 years  old3. 
Acute bacterial conjunctivitis accounts for approximately 50–75% of all conjunctivitis  cases4,5. Streptococcus 
pneumoniae is one of the top three most commonly isolated microorganisms from normal conjunctival  flora6. 
The reported prevalence of S. pneumoniae in healthy conjunctiva ranges from 0 to 4.2%6–9.
S. pneumoniae kills an estimated 317,300 children aged 1–59 months, mostly in lower income  countries10. 
S. pneumoniae causes  meningitis11,  pneumonia12, otitis  media13,  sinusitis14, and acute  conjunctivitis15. S. pneu-
moniae colonization in the nasopharynx is a prerequisite for pneumococcal disease and for  transmission16,17. 
The prevalence of S. pneumoniae carriage in the nasopharynx increases in the first few years of life, peaking at 
approximately 50–80% in children 2–3 years of age, and decreasing thereafter until stabilizing at 5–10% in chil-
dren over 10 years of  age16. Overcrowding (as defined by family size) and day-care attendance are well-established 
factors associated with nasopharyngeal carriage of S. pneumoniae18,19.
S. pneumoniae is responsible for 7–44% of acute conjunctivitis and for 12–20% of conjunctivitis-otitis 
 syndrome20,21. Previous studies found that non-typeable (NT) pneumococci were most likely to cause acute 
 conjunctivitis22,23.
We did not find any previously published studies describing the pneumococcal serotypes detected in the con-
junctiva among members of a community; furthermore, the association between S. pneumoniae prevalence in the 
conjunctiva and the nasopharynx has not been examined yet. We hypothesized that S. pneumoniae in these sites 
would be positively associated, because they are physically connected via the nasolacrimal duct, enabling bacte-
rial transfer between the two niches. The objectives of this study were to determine the prevalence and serotypes 
of S. pneumoniae in conjunctival flora in children aged 4–23 months before the introduction of pneumococcal 
conjugate vaccine (PCV), and to investigate whether S. pneumoniae in the conjunctival flora is associated with 
nasopharyngeal carriage and other host factors. In addition, this study sought to determine whether the serotype 
in the conjunctiva was similar to that detected in the nasopharynx for each participant.
Results
Participants. Six hundred and ninety-eight children aged 4–23 months were enrolled, including six chil-
dren aged 12–13 months. Although the six children aged 12–13 months were not eligible for the wider PCV 
study, we included them in the current study and categorized them in the group aged 12–23 months.
Among the 698 children, 54.2% (n = 378) were boys and the median age at examination was 11.7 months 
(interquartile range, 8.2–17.6). Ninety-nine percent of the children (n = 691) had never had PCV vaccination. 
Conjunctival and nasopharyngeal swabs were collected from all 698 enrolled children. Nasopharyngeal swabs 
were collected from all the 698 mothers of the children.
Prevalence and factors associated with S. pneumoniae in the conjunctiva. Sixty-two children 
(8.9%, 95% CI 6.9–11.2%) had S. pneumoniae in the conjunctiva. Social demographics, clinical characteristics, 
and S. pneumoniae carriage in the child’s and mother’s nasopharynx among children with and without con-
junctival S. pneumoniae are shown in Table 1. Respiratory hospitalization history, cough, runny nose, and eye 
symptoms in the last 2 weeks, day-care attendance, generally in the company of other children under five, and S. 
pneumoniae carriage in the child’s and the mother’s nasopharynx were positively associated with S. pneumoniae 
positive conjunctiva by univariable analysis.
After adjusting potential confounders, low birth-weight, day-care attendance, and having an eye symptom 
in the last 2 weeks independently increased S. pneumoniae detected in the conjunctiva (aOR 11.14, 95% CI 
3.76–32.98, aOR 2.19, 95% CI 1.45–3.31, and aOR 3.59, 95% CI 2.21–5.84, respectively). We determined that S. 
pneumoniae in the nasopharynges were positively associated with S. pneumoniae in the conjunctivae of children 
(adjusted odds ratio [aOR] 47.30, 95% CI 24.07–92.97) (Table 1).
S. pneumoniae serotype distribution in conjunctivae and nasopharynges. The serotype was 
determined in 54 of 62 conjunctival samples positive for S. pneumoniae (87%). Five samples had two different 
serotypes. Of the 59 serotypes reported, non-encapsulated S. pneumoniae (NeSp)  NT224 (n = 35, 59%), 6A (n = 7, 
12%), 6B (n = 5, 8%), and 14 (n = 5, 8%) were most frequently detected in the conjunctivae of children (Fig. 1). 
Twenty-five percent and 37% were PCV10-type and PCV13-type, respectively. Eight serotype-undetermined 
samples included six the autolysin-encoding gene (lytA)-positive with no alpha-hemolytic colony growth and 
two lytA positive with alpha-hemolytic colony growth but no S. pneumoniae confirmed by microarray. Two 
hundred and twelve children (30.5%, 95% CI 27.1–34.0%) had S. pneumoniae in the nasopharynx. The serotype 
was determined for 202 (95%) carriers; 29 (14%) had two serotypes, and 4 (2%) had three serotypes. In total, 
239 serotype calls were reported, and 99 (41%) were PCV10 serotypes and 173 (72%) were PCV13 serotypes. 
Serotype 6A (n = 69, 28.9%) followed by NeSp (n = 53, 22.2%; NT2, n = 51; NT3b, n = 1; NT4b, n = 1), 19F (n = 40, 
16.7%), 6B (n = 29, 12.1%), and 23F (n = 18, 7.5%) were the most frequently detected in the nasopharynges of 
children (Fig. 1). Eighteen mothers out of the 698 (2.6%, 95% CI 1.4–3.8%) had S. pneumoniae in the nasophar-
ynx. The serotype was determined in 17 of the 18 mother’s nasopharyngeal samples with NeSp the most com-
mon (n = 7, 39%; NT2, n = 6; NT3b, n = 1) (Fig. 1).
Forty-seven (87%) of the 54 children with conjunctival pneumococcal detection had at least one serotype that 
matched with S. pneumoniae serotype identified in their nasopharynx. Additionally, these 47 matched serotype 
samples had the same genotype by array CGH analysis of the genome component of the microarray. For the five 
mother’s nasopharyngeal samples of children with conjunctival pneumococcal detection, three samples matched 
by serotype and genotype with the conjunctival and nasopharyngeal samples of their children (Table 2).
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Characteristics
S. pneumoniae positive 
conjunctiva N (%)/mean (SD) 
(n = 62)
S. pneumoniae negative 
conjunctiva N (%)/mean (SD) 
(n = 636)
Crude odds ratio of having S. 
pneumoniae in conjunctiva 
(95% CI)
Adjusted odds  ratioa of having 




 Girl 34 (10.6) 286 (89.4) Reference Reference
 Boy 28 (7.4) 350 (92.6) 0.67 (0.40–1.14) 0.61 (0.26–1.43)
Age
 < 12 months 24 (6.8) 328 (93.2) Reference Reference
 12–23 months 38 (11.0) 308 (89.0) 1.69 (0.99–2.88) 0.84 (0.65–1.08)
Medical history
Birth weight
 ≥ 2500 g 58 (8.5) 622 (91.5) Reference Reference
 < 2500 g (low birth weight) 4 (22.2) 14 (77.8) 3.06 (0.98–9.61) 11.14 (3.76–32.98)
Gestational age at birth
 37 weeks or more 57 (8.7) 602 (91.4) Reference
 < 37 weeks (preterm) 5 (12.8) 34 (87.2) 1.55 (0.58–4.13)
Hospitalization for respiratory disease
 Yes 11 (20.8) 42 (79.3) 3.05 (1.48–6.28)
 No 51 (7.9) 594 (92.1) Reference
Pneumococcal conjugate vaccine history
 Yes (at least one dose) 0 (0.0) 7 (100.0) Not examined
 No 62 (9.0) 629 (91.0) Not examined
Child’s symptom in last 2 weeks
Cough
 Yes 37 (11.9) 274 (88.1) 1.96 (1.15–3.33) 0.73 (0.32–1.63)
 No 25 (6.5) 362 (93.5) Reference Reference
Runny nose
 Yes 41 (12.2) 295 (87.8) 2.26 (1.30–3.91) 1.08 (0.39–3.00)
 No 21 (5.8) 341 (94.2) Reference Reference
Eye symptom
 Yes 10 (30.3) 23 (69.7) 5.13 (2.32–11.34) 3.59 (2.21–5.84)
 No 52 (7.8) 613 (92.2) Reference Reference
Breastfeeding and environment
Breastfeeding until 6 month (including mixed breastfeeding)
 Yes 58 (9.7) 540 (90.3) 2.58 (0.91–7.27)
 No 4 (4.0) 96 (96.0) Reference
Current breastfeeding
 Yes 37 (9.1) 371 (90.9) 1.06 (0.62–1.80)
 No 25 (8.6) 265 (91.4) Reference
Day-care attendance
 Yes 31 (19.4) 129 (80.6) 3.93 (2.30–6.70) 2.19 (1.45–3.31)
 No 31 (5.8) 507 (94.2) Reference Reference
Generally in company with children < 5 years old
 Yes 53 (10.7) 444 (89.3) 2.55 (1.23–5.27)
 No 9 (4.5) 192 (95.5) Reference
Socioeconomic status
Number of family member 5.5 (2.2) 5.5 (2.0) 1.02 (0.90–1.15) 1.08 (0.94–1.23)
Education level of mother
 Elementary school or lower 7 (10.1) 62 (89.9) Reference
 Secondary school 9 (5.7) 150 (94.3) 0.53 (0.19–1.49)
 High school 18 (8.6) 192 (91.4) 0.83 (0.33–2.08)
 College, university or higher 28 (10.8) 232 (89.2) 1.07 (0.45–2.56)
Household income last month 
(million Vietnamese dong) 12.6 (6.3) 11.7 (7.3) 1.02 (0.98–1.05)
Smoker in household
 Yes 35 (8.5) 377 (91.5) 0.89 (0.53–1.51) 0.96 (0.47–1.98)
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Discussion
To our knowledge, this study is the first to report a positive association between conjunctival S. pneumoniae 
detection and nasopharyngeal S. pneumoniae carriage. We conducted a large-scale community-based survey 
using advanced laboratory techniques for the prevalence of S. pneumoniae in a community.
There have been only a few studies describing the prevalence of S. pneumoniae in conjunctivae, which were 
2.2% among people aged from 0 to more than 65 years in  China6, 2.7% among patients awaiting cataract surgery 
whose mean age was 71 years in  Spain25, 3.2% among those aged 1 to 90 in the  UK7, and 0% in the US (no age 
information)8. In this study, the prevalence of S. pneumoniae in the conjunctiva among unvaccinated children 
aged < 24 months in a community was 8.9% (95% CI 6.9–11.2%). The higher prevalence of S. pneumoniae in our 
study may be due to several reasons including participants’ age, geography, and season or climate, considering 
previous reports as follows. Tao et al.6 reported a prevalence of 4.2% in children 0–6 years, and of 1.6% among 
those from 7 to more than 65 years old. Their results were consistent with an earlier study that found a significant 
difference (p < 0.002) in the prevalence of Streptococcus species in the conjunctivae of children (aged 17 years 
Table 1.  Effect of each characteristic on having S. pneumoniae in conjunctiva, estimated using logistic 
regression models. CI confidence interval, SD standard deviation. a Odds ratio of conjunctival S. pneumoniae 
detection for nasopharyngeal S. pneumoniae carriage adjusted by sex, age group (< 12 months or 
12–23 months), cough, runny nose, and eye symptom (eye discharge, red eye, or itching) history in the last 
2 weeks, low birth-weight, child’s day-care attendance, number of family members in the household, presence 
of smokers in the household, and maternal pneumococcal carriage, considering clustering in each commune.
Characteristics
S. pneumoniae positive 
conjunctiva N (%)/mean (SD) 
(n = 62)
S. pneumoniae negative 
conjunctiva N (%)/mean (SD) 
(n = 636)
Crude odds ratio of having S. 
pneumoniae in conjunctiva 
(95% CI)
Adjusted odds  ratioa of having 
S. pneumoniae in conjunctiva 
(95% CI)
Farm animals
 Yes 8 (8.8) 83 (91.2) 0.99 (0.45–2.15)
 No 54 (8.9) 553 (91.1) Reference
Residential area
 Rural 28 (11.6) 213 (88.4) 1.64 (0.97–2.77)
 Urban 34 (7.4) 423 (92.6) Reference
S. pneumoniae carriage
Child’s nasopharynx
 Positive 58 (27.4) 154 (72.6) 45.19 (16.15–126.51) 47.30 (24.07–92.97)
 Negative 4 (0.8) 480 (99.2) Reference Reference
Mother’s nasopharynx
 Positive 5 (27.8) 13 (72.2) 4.20 (1.45–12.21) 2.34 (0.56–9.81)
























Figure 1.  Distribution of serotype of S. pneumoniae detected in the child’s conjunctiva, in the child’s 
nasopharynx, and in the mother’s nasopharynx. NeSp; non-encapsulated Streptococcus pneumoniae. 
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1 14 14 b 14-CGH-01 14-CGH-01 b 
2 14 14 b 14-CGH-01 14-CGH-01 b 
3 14 c b 14-CGH-01 c b 





5 15A 15A b 15A-CGH-01 15A-CGH-01 b 
6 15A 15A b 15A-CGH-01 15A-CGH-01 b 
7 19F 19F b 19F-CGH-01 19F-CGH-01 b 
8 19F 19F b 19F-CGH-01 19F-CGH-01 b 
9 23F 23F b 23F-CGH-01 23F-CGH-01 b 
10 6A 6A b 6A-CGH-01 6A-CGH-01 b 
11 6A 6A b 6A-CGH-01 6A-CGH-01 b 
12 6A 6A b 6A-CGH-01 6A-CGH-01 b 
13 6A 6A b 6A-CGH-01 6A-CGH-01 b 
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Continued
15 6A 6A 19F b 6A-CGH-01 6A-CGH-01; 
19F-CGH-01 
b 






17 6B 6B b 6B-CGH-01 6B-CGH-01 b 
18 6B 6B b 6B-CGH-01 6B-CGH-01 b 




20 6B 14 b 6B-CGH-01 14-CGH-02 b 
21 6B 23F 6B b 6B-CGH-01; 
23F-CGH-01 
6B-CGH-01 b 
22 NT2 19F NT2 b NT2-CGH-01 19F-CGH-01; 
NT2-CGH-01 
b 
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24 NT2 19F NT2 b NT2-CGH-02 19F-CGH-01; 
NT2-CGH-02 
b 




26 NT2 6A NT2 b NT2-CGH-01 6A-CGH-01; 
NT2-CGH-01 
b
27 NT2 6A NT2 b NT2-CGH-01 6A-CGH-01; 
NT2-CGH-01 
b
28 NT2 6A NT2 b NT2-CGH-02 6A-CGH-01; 
NT2-CGH-02 
b




30 NT2 6B NT2 b NT2-CGH-01 6B-CGH-01; 
NT2-CGH-01 
b
31 NT2 NT2 NT2 NT2-CGH-01 NT2-CGH-01 NT2-CGH-01 
32 NT2 NT2 NT2 NT2-CGH-01 NT2-CGH-01 NT2-CGH-01 
33 NT2 NT2 b NT2-CGH-03 NT2-CGH-03 b
8
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34 NT2 NT2 b NT2-CGH-02 NT2-CGH-02 b
35 NT2 NT2 b NT2-CGH-02 NT2-CGH-02 b
36 NT2 NT2 b NT2-CGH-01 NT2-CGH-01 b
37 NT2 NT2 b NT2-CGH-03 NT2-CGH-03 b
38 NT2 NT2 b NT2-CGH-01 NT2-CGH-01 b
39 NT2 NT2 b NT2-CGH-01 NT2-CGH-01 b
40 NT2 NT2 b NT2-CGH-03 NT2-CGH-03 b
41 NT2 NT2 b NT2-CGH-01 NT2-CGH-01 b
42 NT2 NT2 b NT2-CGH-01 NT2-CGH-01 b
43 NT2 NT2 b NT2-CGH-03 NT2-CGH-03 b
44 NT2 NT2 b NT2-CGH-01 NT2-CGH-01 b
45 NT2 NT2 b NT2-CGH-04 NT2-CGH-04 b
46 NT2 NT2 19F b NT2-CGH-03 19F-CGH-01; 
NT2-CGH-03 
b
47 NT2 NT2 6A b NT2-CGH-01 NT2-CGH-01; 
6A-CGH-01 
b
48 NT2 b 19A NT2-CGH-05 b 19A-CGH-01 
49 NT2 b b NT2-CGH-01 b b
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or less) and adults (14.9% versus 2.2%)9. The differences in S. pneumoniae prevalence by age, especially between 
adults and children, may be attributed to several potential mechanisms; including age-related changes in general 
immune responsiveness, tear composition and dynamics, patterns of exposure to bacteria, past antibiotic utiliza-
tion, and the flora of adjacent areas, such as the skin and upper respiratory  tract9. The difference in the prevalence 
of microorganisms in conjunctival flora in relation to geography was described as early as 1954 when results 
from eye cultures from different London based eye hospitals  varied7,26. Seasonal variation in the same area may 
be another important factor. This is supported by a unique study of 4432 patients undergoing cataract surgery 
between 1994 and 1996 in Madrid, which showed rising isolation rates of S. pneumoniae in March, November, 
and December in ocular surface  flora25. Also, these previous studies were conducted in temperate region and the 
bacteria prevalence may be different in tropical as this study. Finally, the methods for detecting S. pneumoniae 
in the conjunctiva of subjects from a community differed between the studies; while the previous studies used 
mostly culture  techniques6–9, this study used highly sensitive and specific approaches, including lytA quantitative 
PCR (qPCR), culture, and DNA  microarray27.
Previously, several studies evaluated correlations among isolates from conjunctivae, middle ear fluids, and 
nasopharynges in conjunctivitis-otitis  syndrome28–30. Bingen et al. used restriction fragment length polymor-
phism to show that paired conjunctiva and middle ear fluid isolates of Haemophilus influenzae were  identical29. 
Groothuis et al. explored the correlation between conjunctival and nasopharyngeal cultures among conjunctivi-
tis-otitis media  syndrome30. However, there have been no studies demonstrating the association of S. pneumoniae 
in conjunctivae and nasopharynges in members of a community. Here, we report the association between S. 
pneumoniae in the conjunctiva and the nasopharynx.
S. pneumoniae is a causative agent of many documented conjunctivitis outbreaks, and NT pneumococci are 
commonly identified as the etiological  agent31–33. The association of NT S. pneumoniae with conjunctivitis was 
first suggested by Finland and Barnes in  197732. Indeed, NT S. pneumoniae have caused several conjunctivitis 
outbreaks in the  USA34,35, and were also recognized as a frequent cause of sporadic cases of conjunctivitis in 
 Spain22. Previous studies found that 23–90% of S. pneumoniae isolates causing conjunctivitis were NT, with higher 
rates after PCV programs were  introduced22,31,33. In studies using phenotypic testing, NTs may include both non-
encapsulated S. pneumoniae as well as isolates for which no serotype was determined (e.g. due to the isolate not 
expressing capsule, or the test not including all serotypes). Keller et al. emphasized that surface proteins unique to 
non-encapsulated S. pneumoniae enhanced colonization and virulence despite the lack of a  capsule33. Our study 
determined that 59% of S. pneumoniae-positive conjunctival samples were NeSp, the majority of which were NT2 
that includes the NspA/PspK surface protein encoded by the null capsule  locus24. Besides, 37% of PCV13-type 
S. pneumoniae might imply the effect of PCV introduction on reducing the prevalence in conjunctiva and also 
incidence of pneumococcal conjunctivitis in this area.
Although S. pneumoniae in nasopharynx and conjunctiva showed concordance in serotype and genotype 
among matched samples from children, the serotype distribution in the two sites was different. The most frequent 
conjunctival serotypes in this study were NeSp, 6A, 6B, 14, 23F, and 19F, among which NeSp had a markedly high 
(59%) and 6A had low (12%) proportion compared to those in the nasopharynx (22% and 29%, respectively) 
among the same subjects. Specific conjunctival factors, including tissue immune responsiveness, tear composi-
tion (immunoglobulins and antimicrobial enzyme lysozyme), dynamics (mechanical action of the eyelids), and 
patterns of exposure to bacteria might have an important role in serotype distribution differences between the 
conjunctiva and the  nasopharynx9,25.
50 NT2 19F b NT2-CGH-01 19F-CGH-01 b
51 NT2 19F b NT2-CGH-01 19F-CGH-01 b
52 NT2 6B b NT2-CGH-01 6B-CGH-01 b
53 NT2 14 14 b NT2-CGH-01; 
14-CGH-01 
14-CGH-01 b
54 NT2 23F 23F b NT2-CGH-03; 
23F-CGH-02 
23F-CGH-02 b
Table 2.  Serotypes and genotypes of S. pnuemoniae detected in children’s conjunctiva and nasopharynx and 
their mothers’ nasopharynx among children with serotype-determined conjunctival S. pneumoniae. a Shaded 
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In our study, the lower rate of conjunctival S. pneumoniae detection than nasopharyngeal carriage, and the 
concordance of serotype and genotype in matched samples, might indicate that colonization of S. pneumoniae 
starts in the nasopharynx and spreads to the conjunctiva. Also, the tear composition and dynamics explained 
above might make it more difficult for potentially pathogenic microorganisms to colonize the conjunctival 
 surface9. S. pneumoniae can be plausibly transmitted from the nasopharynx to the conjunctiva through the 
nasolacrimal duct, by the retrograde passage of fluid from the nose to the conjunctiva during nasal congestion 
and because of short ducts during infancy and early childhood. Also, S. pneumoniae may reach the conjunctival 
sac from the skin, the surrounding environment, hand contamination, and through contact with persons such 
as the  mother36. The low nasopharyngeal carriage prevalence of mothers in this study indicates that they were 
unlikely to be the major source of transmission. We did not investigate the conjunctival S. pneumoniae prevalence 
in mothers in this study; however, it would be interesting to consider the same in a future study with a larger 
sample size to determine the prevalence in mothers and the potential transmission route.
To our knowledge, this is the first study to investigate risk factors related to conjunctival S. pneumoniae detec-
tion in children. Whilst we anticipated that age would be a risk factor for conjunctival S. pneumoniae detection, 
we did not find a difference in our study, most likely because the paediatric groups were relatively similar in age. 
Day-care attendance increased conjunctival S. pneumoniae detection in this study. Day-care attendance is a well-
established factor associated with nasopharyngeal S. pneumoniae  carriage16,19,37,38. Our results are in accordance 
with Sthapit et al., who showed that conjunctival bacterial flora is similar in either  sex39. This study also deter-
mined that low birth-weight increased S. pneumoniae detection in the conjunctiva in children < 24 months. This 
may be because of the susceptibility of low birth-weight children to infectious diseases, compared to normal birth 
weight children, due to poor immune  responses40. In contrast, the decreased nasopharyngeal carriage risk with 
low birth-weight was a surprising finding, though this result has been reported in Dutch and Indian  babies19,41.
There are some limitations to the study. First, this was a cross-sectional study conducted in October 2016, and 
results may vary by season. Longitudinal studies may also provide insight as to whether detection of S. pneumo-
niae in the conjunctiva of children in a community is a true carriage, such as observed in the nasopharynx. In a 
few cases, the prevalence of pneumococcal strains was determined by positive lytA detection only. It should be 
considered that other related streptococcal species may also have lytA homologues and could yield false-positive 
results. Nevertheless, this accounted for a minor proportion, which would not have affected the findings of this 
study. In addition, we did not assess the presence of viruses or other bacterial species in this study.
Nearly 9% of children in a central Vietnamese community aged < 24 months had S. pneumoniae in the con-
junctiva before introduction of PCV in the community. We have reported the novel finding that S. pneumoniae 
in the conjunctiva was positively associated with that in the nasopharynx, and that the serotypes and genotypes 
in the conjunctiva mostly matched those in the nasopharynx for each child. These findings suggest that the 
nasopharynx may be a source of transmission for S. pneumoniae to the conjunctiva. Nevertheless, there was 
some evidence also for a different serotype distribution in nasopharynx and in conjunctiva of study subjects. In 
addition, there was a high proportion of NeSp in the conjunctiva. Our data provide further evidence that NeSp 
has a unique ability to colonize in the ocular environment.
Methods
Study site and participants. The study was conducted in six communes in the city of Nha Trang, central 
Vietnam. Nha Trang has 27 communes and each commune has one commune health center, providing a range 
of basic health services. In the study area, two communes were zoned as rural and four as urban areas, by the 
administrative boundary. A PCV-reduced dosing schedule trial has been initiated in this study  site42, and the 
current study was a part of the pre-PCV baseline assessment of the trial (https ://clini caltr ials.gov/ct2/show/
NCT02 96123 1).
In each commune, 60 children, each from two target age groups, aged 4–11 months (younger group) and 
14–23 months (older group), were randomly selected using the commune population registration records for 
enrolment into the study, regardless of current respiratory or eye symptoms. The populations of target age groups 
in this study, within the study area of the 6 communes, were 1004 for 4–11 months and 1590 for 14–23 months. 
The randomly selected children and their mothers were invited for examination and interview at the commune 
health center in each commune, in October 2016, before the introduction of PCV. Written informed consent was 
obtained from all parents or guardians before collecting samples and conducting interviews.
Data, sample collection, and testing. A trained healthcare worker in each commune health center 
interviewed each participant’s mother to collect demographic, socioeconomic, and clinical information using 
a structured interview form. Data collected included: sex, date of birth, birth-weight, gestational age at birth, if 
the child has ever been hospitalized for respiratory disease, PCV history, current symptoms in the last 2 weeks 
(cough, runny nose, eye symptoms including eye discharge, red eye, itchy eye, and others), breast feeding history, 
child’s day-care attendance, whether the child is usually living with other children aged under five, education 
level of the mother, household income last month, family members smoking, household having farm animals, 
and residential area. Births were defined as preterm if children were born < 37 gestational weeks, and of low 
birth-weight if the birth-weight was < 2500 g, following the guidelines in the International Classification of Dis-
eases-10: version  201043. The child’s conjunctival and nasopharyngeal swabs, and the mother’s nasopharyngeal 
swabs, were obtained by a doctor using a nylon flocked swab and stored in skim milk, tryptone, glucose, and 
glycerol (STGG) medium according to WHO  guidelines44.
Swabs were sent to the Pasteur Institute Nha Trang, where DNA extraction and real-time qPCR targeting 
lytA of S. pneumoniae was performed. Samples that were positive (Ct value < 35) or equivocal (Ct value 35–40) 
by qPCR-testing were cultured on selective agar, and DNA was extracted from bacterial growth on the QIAcube 
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HT (Qiagen, Hilden, Germany) platform as previously  described45. The extracted DNA was sent to the Murdoch 
Children’s Research Institute, Melbourne, Australia, for molecular serotyping by microarray (Senti-SP v1.5, BUGS 
Bioscience, London, UK; http://bugsb io.org) to determine the serotype and genotype of S. pneumoniae present in 
the conjunctival and nasopharyngeal samples. Pneumococcal carriage and the presence of each pneumococcal 
serotype were determined by microarray. Samples that were lytA qPCR positive (Ct value < 35) but not able to 
be serotyped (either culture negative or low DNA yield from culture) were considered pneumococcal positive, 
serotype  unknown45.
Sample size. Sample size was calculated based on the primary outcome of presence of conjunctival S. pneu-
moniae. We assumed the true proportion of children aged < 24 months in the study area who have S. pneumoniae 
in the conjunctiva to be 0.5 to obtain the largest sample size, and required the estimate to be within 0.04 of the 
true value (precision) within the 95% confidence interval (CI). Then, the minimum sample size was calculated 
to be 600.
Ethical considerations. Institutional Review Boards at the National Institute of Hygiene and Epidemiol-
ogy, Hanoi, Vietnam (the approval number VN01057), and the Institute of Tropical Medicine, Nagasaki Univer-
sity, Nagasaki, Japan (151203149-2), approved this study. All methods were performed in accordance with the 
relevant guidelines and regulations.
Statistical analysis. We calculated the prevalence of conjunctival and nasopharyngeal S. pneumoniae 
among children < 24 months and that of nasopharyngeal S. pneumoniae among their mothers in the study area. 
S. pneumoniae serotype distribution in the conjunctiva and nasopharynx were shown graphically and the con-
cordance was evaluated. We showed the number and the proportion of children with the same S. pneumoniae 
serotype/genotype in the nasopharynx and in the conjunctiva. We compared demographic, socioeconomic, and 
clinical characteristics, and S. pneumoniae prevalence in the nasopharynges of the children and mothers between 
children with and without conjunctival S. pneumoniae. Crude odds ratios of conjunctival S. pneumoniae detec-
tion were analyzed for each characteristic using logistic regression. Based on previous studies of risk factors 
associated with conjunctival bacterial  prevalence6,39 or nasopharyngeal S. pneumoniae  carriage16,19,46,47, the fol-
lowing potential confounders were selected a priori and included in a model to estimate the effect of the child’s 
nasopharyngeal S. pneumoniae carriage on conjunctival S. pneumoniae detection: sex, age group (< 12 months 
or 12–23 months), cough, runny nose, and eye symptoms (eye discharge, red eye, or itching) history in the last 
2 weeks, low birth-weight, day-care attendance, number of family members in the household, presence of smok-
ers in the household, and maternal pneumococcal carriage. CIs were adjusted for the clustering of communes 
using robust standard errors. Statistical analyses were conducted using Stata version 14.0 software (StataCorp. 
2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP).
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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